Tue, January 21, 2025
Mon, January 20, 2025
Sun, January 19, 2025

Ozempic-style drugs tied to more than 60 health benefits and risks in biggest study-of-its-kind

  Copy link into your clipboard //health-fitness.news-articles.net/content/2025/ .. fits-and-risks-in-biggest-study-of-its-kind.html
  Print publication without navigation Published in Health and Fitness on by MSN
          🞛 This publication is a summary or evaluation of another publication 🞛 This publication contains editorial commentary or bias from the source
Weight-loss drugs like Ozempic may decrease your risk of developing 42 health conditions, but increase your chance of experiencing 19 others, according to one of the most comprehensive studies-of-its-kind to date.
The article from MSN discusses a comprehensive study on GLP-1 agonists like Ozempic, which are primarily used for managing type 2 diabetes and weight loss. This study, the largest of its kind, analyzed data from over 16 million patients and identified over 60 health benefits and risks associated with these drugs. Key findings include significant weight loss, reduced risk of cardiovascular events, and improvements in blood sugar control. However, the drugs were also linked to potential side effects like an increased risk of gastrointestinal issues, including nausea and diarrhea, and a higher incidence of certain cancers, although the latter needs further investigation. The study underscores the dual nature of these medications, offering substantial health benefits while also presenting notable risks that require careful management and monitoring by healthcare providers.

Read the Full MSN Article at:
[ https://www.msn.com/en-us/health/diseases-and-conditions/ozempic-style-drugs-tied-to-more-than-60-health-benefits-and-risks-in-biggest-study-of-its-kind/ar-AA1xxw66 ]